ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1128

The Diagnosis of Systemic Sclerosis as a Traumatic Experience: Patients’ Reactions to the Diagnostic Process

Fennell Patricia1, Lee Shapiro2, Nancy Dorr3, Roberta Lukasiewicz4, Frank Houser5 and Madison Taylor6, 1Albany Health Management Associates, Steffens Scleroderma Foundation, Albany, NY, 2Albany Medical College, Stillwater, NY, 3The College of Saint Rose, Albany, NY, 4Steffens Scleroderma Foundation, Albany, NY, 5The College of Saint Rose, Nassau, NY, 6The College of Saint Rose, Mississauga, ON, Canada

Meeting: ACR Convergence 2020

Keywords: Emotions, Systemic sclerosis, Trauma

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2020

Title: Patient Outcomes, Preferences, & Attitudes Poster II: Miscellaneous Rheumatic Diseases

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Both the process of being diagnosed with a chronic illness and the illness itself can be a traumatizing experience (1).  The current study examined the diagnosis of a chronic illness, systemic sclerosis (SSc), as a potentially traumatic experience. We examined SSc patients’ perceptions of the process of getting diagnosed and their reactions to this diagnosis.  Our research question was, “What do patients report experiencing regarding the process of being diagnosed with SSc?”

Methods: Patients with SSc were approached to participate by their rheumatologist (specializing in SSc) during an office visit.  Sixty-four patients completed the study (42% diffuse, 45% limited, 13% unknown type of SSc).   All patients included met ACR-Eular criteria for diagnosis of SSc.  Most respondents were female (85%), white (95%), and had an average age of 61 years.

Patients completed open-ended questions (e.g., what prompted you to first go to the doctor, what occurred through the time you were diagnosed with SSc, how did you react to the diagnosis).  Two researchers independently categorized responses.  Discrepancies were resolved by discussion.  Additionally, one researcher retrieved demographic and disease information from patients’ records.

Results: Seventeen percent of the sample received a potentially traumatic message from a health professional during the diagnostic process.  For example, one patient reported learning there was no treatment for SSc and it would continue to get worse, one reported being told she was dying (before SSc was diagnosed), and another reported physicians involved in the diagnostic process were dismissive of independent and seemingly unrelated symptoms.

As can be seen in Table 1, fear was the most common patient reaction, especially fear of the future and fear of dying. Other reactions were feeling upset about not having a diagnosis (before SSc was diagnosed), feeling concern because of the disease progression they witnessed in others, feeling anticipatory grief, feeling sad or shock, and questioning their ability to cope.

Conclusion: Diagnosing and treating chronic illness can be a difficult process for both patients and practitioners (1).  Consistent with past research, reactions to the diagnostic process showed patients did not self-label their reactions as depression (2).  In the current study, few patients even reported sadness; fear was the overwhelmingly common reaction.

The current data emphasize the importance of physicians attending to the way information regarding SSc is conveyed to patients.  Although a majority did not report receiving traumatic messages from a health care professional during the diagnostic process, over 1 in 6 patients did.  Given the diagnostic process for SSc can be lengthy, patients may be feeling distressed for years.  Health providers working with SSc patients should address patients’ emotions and the causes of them (e.g., internet, statement by health provider) and know that their conversations with patients can make a difference.
References:

  1. Fennell PA Managing chronic illness using the Four-Phase Treatment Approach. Wiley; 2003
  2. Newton EG, Thombs BD, Groleau D. The experience of emotional distress among women living with scleroderma. Qual Health Res 2012; 22: 1195-1206.

Table 1. Reactions to Being Diagnosed With SSc and Percent of Patients Who Reported Each Reaction


Disclosure: F. Patricia, None; L. Shapiro, Actelion, 5; N. Dorr, None; R. Lukasiewicz, None; F. Houser, None; M. Taylor, None.

To cite this abstract in AMA style:

Patricia F, Shapiro L, Dorr N, Lukasiewicz R, Houser F, Taylor M. The Diagnosis of Systemic Sclerosis as a Traumatic Experience: Patients’ Reactions to the Diagnostic Process [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/the-diagnosis-of-systemic-sclerosis-as-a-traumatic-experience-patients-reactions-to-the-diagnostic-process/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-diagnosis-of-systemic-sclerosis-as-a-traumatic-experience-patients-reactions-to-the-diagnostic-process/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology